COVID-19 Disease and Vitamin D: A Mini-Review

21Citations
Citations of this article
118Readers
Mendeley users who have this article in their library.

Abstract

Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19.

Cite

CITATION STYLE

APA

Boulkrane, M. S., Ilina, V., Melchakov, R., Fedotova, J., Drago, F., Gozzo, L., … Baranenko, D. (2020, December 17). COVID-19 Disease and Vitamin D: A Mini-Review. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2020.604579

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free